Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 94.39 | 2.48 |
| PEG Ratio (TTM) | -2.25 | 4.95 |
| P/S Ratio (TTM) | 1.77 | 1.47 |
| P/B Ratio (TTM) | 2.53 | 4.99 |
| P/FCF Ratio (TTM) | 19.13 | 3.81 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.71 |
| Price to 5YR AVG FCF Ratio | N/A | 21.76 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.00% | 5.80% |
| ROE (TTM) | 2.76% | 11.07% |
| Net Profit Margin (TTM) | 1.98% | 5.72% |
| ROIC 5YR AVG | N/A | 14.25% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -75.04% | 2,905.24% | N/A |
| Revenue | 0.56% | 72.72% | N/A |
| Net Income | -75.21% | 2,933.82% | N/A |
| Cash Flow | -6.58% | 95.10% | N/A |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.58 | 1.98 |
| Quick Ratio (TTM) | 3.28 | 1.18 |
| D/E Ratio (TTM) | N/A | 1.57 |
| Interest Coverage (TTM) | 0.97 | 11.67 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 6.28 | 3.70 |
| LTL to 5YR AVG FCF | N/A | 5.35 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.18% |